{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T18:07:04Z","timestamp":1791137224650,"version":"4.1.0"},"reference-count":41,"publisher":"American Association for Cancer Research (AACR)","issue":"19","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2007,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Intestinal radiation injury is dose limiting during abdominal and pelvic radiotherapy and critical for the outcome after accidental whole-body radiation exposure. The multifunctional cytokine, interleukin-11 (IL-11), ameliorates the intestinal radiation response, but its clinical use is hampered by severe toxicity after systemic administration. This study addressed whether protection against intestinal radiation injury can be achieved by intraluminal administration of IL-11. Male rats underwent surgical transposition of a 4-cm small bowel loop to the scrotum. For repeated intraluminal drug administration, an ileostomy, proximal to the bowel loop in the scrotum, was created. The transposed intestinal loop was exposed to 5 Gy fractions on 9 consecutive days. Recombinant human IL-11 (rhIL-11; 2 mg\/kg\/d) or vehicle was given through the ileostomy from 2 days before until 2 weeks after irradiation. At 2 weeks, structural, cellular, and molecular aspects of intestinal radiation injury were assessed. rhIL-11 ameliorated structural manifestations of radiation enteropathy, including radiation injury score (6.5 \u00b1 0.6 in the vehicle group versus 4.0 \u00b1 0.3 in the IL-11 group; P = 0.001), mucosal surface area loss (0.2 \u00b1 0.1 versus 0.5 \u00b1 0.03; P &amp;lt; 0.0001), and intestinal wall thickening (842 \u00b1 66 \u03bcm versus 643 \u00b1 54 \u03bcm; P = 0.02), reduced postradiation transforming growth factor-\u03b2 overexpression, and reduced numbers of ED2-positive cells. Postirradiation mucosal mast cell numbers were partially restored by rhIL-11. These data show that local administration of rhIL-11 ameliorates early intestinal radiation injury and support further development of rhIL-11 to reduce manifestations of intestinal radiation injury in the clinic. [Cancer Res 2007;67(19):9501\u20136]<\/jats:p>","DOI":"10.1158\/0008-5472.can-07-0810","type":"journal-article","created":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T19:03:18Z","timestamp":1191265398000},"page":"9501-9506","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Local Administration of Interleukin-11 Ameliorates Intestinal Radiation Injury in Rats"],"prefix":"10.1158","volume":"67","author":[{"given":"Marjan","family":"Boerma","sequence":"first","affiliation":[{"name":"1Pharmaceutical Sciences, Departments of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junru","family":"Wang","sequence":"additional","affiliation":[{"name":"2Surgery,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander F.","family":"Burnett","sequence":"additional","affiliation":[{"name":"3Obstetrics and Gynecology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro D.","family":"Santin","sequence":"additional","affiliation":[{"name":"3Obstetrics and Gynecology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan J.","family":"Roman","sequence":"additional","affiliation":[{"name":"3Obstetrics and Gynecology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Hauer-Jensen","sequence":"additional","affiliation":[{"name":"4Surgery and Pathology, University of Arkansas for Medical Sciences;"},{"name":"5Surgery Service, Central Arkansas Veterans Healthcare System, Little Rock, Arkansas"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2007,10,1]]},"reference":[{"key":"2022061623235784000_B1","doi-asserted-by":"crossref","unstructured":"Andreyev J. Gastrointestinal complications of pelvic radiotherapy: are they of any importance? Gut\u20082005; 54: 1051\u20134.","DOI":"10.1136\/gut.2004.062596"},{"key":"2022061623235784000_B2","doi-asserted-by":"crossref","unstructured":"Sonis ST, Elting LS, Keefe D, et al. Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer\u20082004; 100: 1995\u20132025.","DOI":"10.1002\/cncr.20162"},{"key":"2022061623235784000_B3","doi-asserted-by":"crossref","unstructured":"Richter KK, Wang J, Fagerhol MK, Hauer-Jensen M. Radiation-induced granulocyte transmigration predicts development of delayed structural changes in rat intestine. Radiother Oncol\u20082001; 59: 81\u20135.","DOI":"10.1016\/S0167-8140(00)00302-9"},{"key":"2022061623235784000_B4","doi-asserted-by":"crossref","unstructured":"Johnson LB, Riaz AA, Adawi D, et al. Radiation enteropathy and leucocyte-endothelial cell reactions in a refined small bowel model. BMC Surg\u20082004; 4: 10.","DOI":"10.1186\/1471-2482-4-10"},{"key":"2022061623235784000_B5","doi-asserted-by":"crossref","unstructured":"Denham JW, Hauer-Jensen M. The radiotherapeutic injury\u2014a complex \u2018wound\u2019. Radiother Oncol\u20082002; 63: 129\u201345.","DOI":"10.1016\/S0167-8140(02)00060-9"},{"key":"2022061623235784000_B6","doi-asserted-by":"crossref","unstructured":"Langberg CW, Hauer-Jensen M, Sung CC, Kane CJ. Expression of fibrogenic cytokines in rat small intestine after fractionated irradiation. Radiother Oncol\u20081994; 32: 29\u201336.","DOI":"10.1016\/0167-8140(94)90446-4"},{"key":"2022061623235784000_B7","doi-asserted-by":"crossref","unstructured":"Kawashima R, Kawamura YI, Kato R, et al. IL-13 receptor \u03b12 promotes epithelial cell regeneration from radiation-induced small intestinal injury in mice. Gastroenterology\u20082006; 131: 130\u201341.","DOI":"10.1053\/j.gastro.2006.04.022"},{"key":"2022061623235784000_B8","doi-asserted-by":"crossref","unstructured":"Boerma M, Wang J, Richter KK, Hauer-Jensen M. Orazipone, a locally acting immunomodulator, ameliorates intestinal radiation injury: a preclinical study in a novel rat model. Int J Radiat Oncol Biol Phys\u20082006; 66: 552\u20139.","DOI":"10.1016\/j.ijrobp.2006.05.067"},{"key":"2022061623235784000_B9","doi-asserted-by":"crossref","unstructured":"Schwertschlag US, Trepicchio WL, Dykstra KH, et al. Hematopoietic, immunomodulatory and epithelial effects of interleukin-11. Leukemia\u20081999; 13: 1307\u201315.","DOI":"10.1038\/sj.leu.2401514"},{"key":"2022061623235784000_B10","doi-asserted-by":"crossref","unstructured":"Ropeleski MJ, Tang J, Walsh-Reitz MM, Musch MW, Chang EB. Interleukin-11-induced heat shock protein 25 confers intestinal epithelial-specific cytoprotection from oxidant stress. Gastroenterology\u20082003; 124: 1358\u201368.","DOI":"10.1016\/S0016-5085(03)00282-8"},{"key":"2022061623235784000_B11","unstructured":"Tepler I, Elias L, Smith JW, et al. A randomized placebo-controlled trial of recombinant human interleukin-11 in cancer patients with severe thrombocytopenia due to chemotherapy. Blood\u20081996; 87: 3607\u201314."},{"key":"2022061623235784000_B12","doi-asserted-by":"crossref","unstructured":"Sands BE, Winston BD, Salzberg B, et al. Randomized, controlled trial of recombinant human interleukin-11 in patients with active Crohn's disease. Aliment Pharmacol Ther\u20082002; 16: 399\u2013406.","DOI":"10.1046\/j.1365-2036.2002.01179.x"},{"key":"2022061623235784000_B13","doi-asserted-by":"crossref","unstructured":"Du XX, Doerschuk CM, Orazi A, Williams DA. A bone marrow stromal-derived growth factor, interleukin-11, stimulates recovery of small intestinal mucosal cells after cytoablative therapy. Blood\u20081994; 83: 33\u20137.","DOI":"10.1182\/blood.V83.1.33.bloodjournal83133"},{"key":"2022061623235784000_B14","doi-asserted-by":"crossref","unstructured":"Potten CS. Protection of the small intestinal clonogenic stem cells from radiation-induced damage by pretreatment with interleukin 11 also increases murine survival time. Stem Cells\u20081996; 14: 452\u20139.","DOI":"10.1002\/stem.140452"},{"key":"2022061623235784000_B15","doi-asserted-by":"crossref","unstructured":"Booth D, Potten CS. Protection against mucosal injury by growth factors and cytokines. J Natl Cancer Inst Monogr\u20082001; 2001: 16\u201320.","DOI":"10.1093\/oxfordjournals.jncimonographs.a003433"},{"key":"2022061623235784000_B16","doi-asserted-by":"crossref","unstructured":"Dykstra KH, Rogge H, Stone A, et al. Mechanism and amelioration of recombinant human interleukin-11 (rhIL-11)-induced anemia in healthy subjects. J Clin Pharmacol\u20082000; 40: 880\u20138.","DOI":"10.1177\/00912700022009521"},{"key":"2022061623235784000_B17","doi-asserted-by":"crossref","unstructured":"Antin JH, Lee SJ, Neuberg D, et al. A phase I\/II double-blind, placebo-controlled study of recombinant human interleukin-11 for mucositis and acute GVHD prevention in allogeneic stem cell transplantation. Bone Marrow Transplant\u20082002; 29: 373\u20137.","DOI":"10.1038\/sj.bmt.1703394"},{"key":"2022061623235784000_B18","doi-asserted-by":"crossref","unstructured":"Cotreau MM, Stonis L, Strahs A, Schwertschlag US. A multiple-dose, safety, tolerability, pharmacokinetics and pharmacodynamic study of oral recombinant human interleukin-11 (oprelvekin). Biopharm Drug Dispos\u20082004; 25: 291\u20136.","DOI":"10.1002\/bdd.415"},{"key":"2022061623235784000_B19","doi-asserted-by":"crossref","unstructured":"Guo HL, Wolfe D, Epperly MW, et al. Gene transfer of human manganese superoxide dismutase protects small intestinal villi from radiation injury. J Gastrointest Surg\u20082003; 7: 229\u201335.","DOI":"10.1016\/S1091-255X(02)00186-5"},{"key":"2022061623235784000_B20","doi-asserted-by":"crossref","unstructured":"Hauer-Jensen M, Poulakos L, Osborne JW. Effects of accelerated fractionation on radiation injury of the small intestine: a new rat model. Int J Radiat Oncol Biol Phys\u20081988; 14: 1205\u201312.","DOI":"10.1016\/0360-3016(88)90399-9"},{"key":"2022061623235784000_B21","doi-asserted-by":"crossref","unstructured":"Langberg CW, Sauer T, Reitan JB, Hauer-Jensen M. Relationship between intestinal fibrosis and histopathologic and morphometric changes in consequential and late radiation enteropathy. Acta Oncol\u20081996; 35: 81\u20137.","DOI":"10.3109\/02841869609098484"},{"key":"2022061623235784000_B22","doi-asserted-by":"crossref","unstructured":"Baddeley AJ, Gundersen HJ, Cruz-Orive LM. Estimation of surface area from vertical sections. J Microsc\u20081986; 142: 259\u201376.","DOI":"10.1111\/j.1365-2818.1986.tb04282.x"},{"key":"2022061623235784000_B23","doi-asserted-by":"crossref","unstructured":"Wang J, Zheng H, Sung CC, Richter KK, Hauer-Jensen M. Cellular sources of transforming growth factor-\u03b2 isoforms in early and chronic radiation enteropathy. Am J Pathol\u20081998; 153: 1531\u201340.","DOI":"10.1016\/S0002-9440(10)65741-0"},{"key":"2022061623235784000_B24","doi-asserted-by":"crossref","unstructured":"Trepicchio WL, Wang L, Bozza M, Dorner AJ. IL-11 regulates macrophage effector function through the inhibition of nuclear factor-\u03baB. J Immunol\u20081997; 159: 5661\u201370.","DOI":"10.4049\/jimmunol.159.11.5661"},{"key":"2022061623235784000_B25","doi-asserted-by":"crossref","unstructured":"Peterson RL, Wang L, Albert L, Keith JC, Jr., Dorner AJ. Molecular effects of recombinant human interleukin-11 in the HLA-B27 rat model of inflammatory bowel disease. Lab Invest\u20081998; 78: 1503\u201312.","DOI":"10.1016\/S0016-5085(98)84313-8"},{"key":"2022061623235784000_B26","unstructured":"Rodemann HP, Binder A, Burger A, et al. The underlying cellular mechanism of fibrosis. Kidney Int Suppl\u20081996; 54: S32\u20136."},{"key":"2022061623235784000_B27","doi-asserted-by":"crossref","unstructured":"Barcellos-Hoff MH. How do tissues respond to damage at the cellular level? The role of cytokines in irradiated tissues. Radiat Res\u20081998; 150: S109\u201320.","DOI":"10.2307\/3579813"},{"key":"2022061623235784000_B28","doi-asserted-by":"crossref","unstructured":"Zheng H, Wang J, Koteliansky VE, Gotwals PJ, Hauer-Jensen M. Recombinant soluble transforming growth factor \u03b2 type II receptor ameliorates radiation enteropathy in mice. Gastroenterology\u20082000; 119: 1286\u201396.","DOI":"10.1053\/gast.2000.19282"},{"key":"2022061623235784000_B29","unstructured":"Orazi A, Du X, Yang Z, Kashai M, Williams DA. Interleukin-11 prevents apoptosis and accelerates recovery of small intestinal mucosa in mice treated with combined chemotherapy and radiation. Lab Invest\u20081996; 75: 33\u201342."},{"key":"2022061623235784000_B30","doi-asserted-by":"crossref","unstructured":"Wang RJ, Peng RY, Fu KF, et al. Effect of recombinant human interleukin-11 on expressions of interleukin-11 receptor \u03b1-chain and glycoprotein 130 in intestinal epithelium cell line-6 after neutron irradiation. World J Gastroenterol\u20082006; 12: 3055\u20139.","DOI":"10.3748\/wjg.v12.i19.3055"},{"key":"2022061623235784000_B31","unstructured":"Peterson RL, Bozza MM, Dorner AJ. Interleukin-11 induces intestinal epithelial cell growth arrest through effects on retinoblastoma protein phosphorylation. Am J Pathol\u20081996; 149: 895\u2013902."},{"key":"2022061623235784000_B32","doi-asserted-by":"crossref","unstructured":"Potten CS, Booth D, Haley JD. Pretreatment with transforming growth factor \u03b2-3 protects small intestinal stem cells against radiation damage in vivo. Br J Cancer\u20081997; 75: 1454\u20139.","DOI":"10.1038\/bjc.1997.249"},{"key":"2022061623235784000_B33","doi-asserted-by":"crossref","unstructured":"Gyotoku E, Morita E, Kameyoshi Y, et al. The IL-6 family cytokines, interleukin-6, interleukin-11, oncostatin M, and leukemia inhibitory factor, enhance mast cell growth through fibroblast-dependent pathway in mice. Arch Dermatol Res\u20082001; 293: 508\u201314.","DOI":"10.1007\/PL00007465"},{"key":"2022061623235784000_B34","doi-asserted-by":"crossref","unstructured":"Zheng H, Wang J, Hauer-Jensen M. Role of mast cells in early and delayed radiation injury in rat intestine. Radiat Res\u20082000; 153: 533\u20139.","DOI":"10.1667\/0033-7587(2000)153[0533:ROMCIE]2.0.CO;2"},{"key":"2022061623235784000_B35","unstructured":"Stead RH. Innervation of mucosal immune cells in the gastrointestinal tract. Reg Immunol\u20081992; 4: 91\u20139."},{"key":"2022061623235784000_B36","doi-asserted-by":"crossref","unstructured":"Venkova K, Keith JC, Jr., Greenwood-Van Meerveld B. Oral treatment with recombinant human interleukin-11 improves mucosal transport in the colon of human leukocyte antigen-B27 transgenic rats. J Pharmacol Exp Ther\u20082004; 308: 206\u201313.","DOI":"10.1124\/jpet.103.058701"},{"key":"2022061623235784000_B37","doi-asserted-by":"crossref","unstructured":"Wang J, Zheng H, Kulkarni A, Ou X, Hauer-Jensen M. Regulation of early and delayed radiation responses in rat small intestine by capsaicin-sensitive nerves. Int J Radiat Oncol Biol Phys\u20082006; 64: 1528\u201336.","DOI":"10.1016\/j.ijrobp.2005.12.035"},{"key":"2022061623235784000_B38","doi-asserted-by":"crossref","unstructured":"Yamazumi K, Nakayama T, Kusaba T, et al. Expression of interleukin-11 and interleukin-11 receptor \u03b1 in human colorectal adenocarcinoma; immunohistochemical analyses and correlation with clinicopathological factors. World J Gastroenterol\u20082006; 12: 317\u201321.","DOI":"10.3748\/wjg.v12.i2.317"},{"key":"2022061623235784000_B39","doi-asserted-by":"crossref","unstructured":"Deutscher N, Bataille F, Hausmann M, et al. Functional expression of the interleukin-11 receptor \u03b1-chain in normal colonic epithelium and colon cancer. Int J Colorectal Dis\u20082006; 21: 573\u201381.","DOI":"10.1007\/s00384-005-0055-8"},{"key":"2022061623235784000_B40","doi-asserted-by":"crossref","unstructured":"Booth C, Potten CS. Effects of IL-11 on the growth of intestinal epithelial cells in vitro. Cell Prolif\u20081995; 28: 581\u201394.","DOI":"10.1111\/j.1365-2184.1995.tb00046.x"},{"key":"2022061623235784000_B41","doi-asserted-by":"crossref","unstructured":"Redlich CA, Gao X, Rockwell S, Kelley M, Elias JA. IL-11 enhances survival and decreases TNF production after radiation-induced thoracic injury. J Immunol\u20081996; 157: 1705\u201310.","DOI":"10.4049\/jimmunol.157.4.1705"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/67\/19\/9501\/2572648\/9501.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/67\/19\/9501\/2572648\/9501.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,14]],"date-time":"2023-05-14T09:00:41Z","timestamp":1684054841000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/67\/19\/9501\/533417\/Local-Administration-of-Interleukin-11-Ameliorates"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10,1]]},"references-count":41,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2007,10,1]]},"published-print":{"date-parts":[[2007,10,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-07-0810","relation":{},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,10,1]]}}}